Cas:24948-05-8 (1R,2S)-2-(aminomethyl)cyclohexan-1-ol,hydrochloride manufacturer & supplier

We serve Chemical Name:(1R,2S)-2-(aminomethyl)cyclohexan-1-ol,hydrochloride CAS:24948-05-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(1R,2S)-2-(aminomethyl)cyclohexan-1-ol,hydrochloride

Chemical Name:(1R,2S)-2-(aminomethyl)cyclohexan-1-ol,hydrochloride
CAS.NO:24948-05-8
Synonyms:trans-2-(Aminomethyl)cyclohexanol hydrochloride
Molecular Formula:C7H16ClNO
Molecular Weight:165.66100
HS Code:2922199090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:46.25000
Exact Mass:165.09200
LogP:1.99850

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like trans-2-(Aminomethyl)cyclohexanol hydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,trans-2-(Aminomethyl)cyclohexanol hydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,trans-2-(Aminomethyl)cyclohexanol hydrochloride Use and application,trans-2-(Aminomethyl)cyclohexanol hydrochloride technical grade,usp/ep/jp grade.


Related News: So-called “off” periods occur when a Parkinson’s patient has difficulty moving about and occur when the effect of the last dose of another common Parkinson’s drug, known as levodopa, wears off. (2R,4R)-4-hydroxy-2-[2-[2-[2-(3-methoxyphenyl)ethyl]phenoxy]ethyl]-1-methylpyrrolidine manufacturers As we expand our offering into the US and beyond, NOVA aims to become the go-to partner for pharma and biotech companies for in silico clinical trial support. I am delighted to welcome Grégoire to the Novadiscovery team and look forward to working closely with him.” N,N-dimethylbutan-2-amine suppliers However, to leverage these benefits, it is vital that biocatalytic processes be evaluated as early in the drug development life cycle as possible. Fortunately, the growing availability of diverse kits of enzyme classes can facilitate this process, allowing researchers to screen enzymes/biocatalysts in much the same way as traditional screening of metal catalysts is performed. (3,3-dichlorooxolan-2-yl) formate vendor & factory.